Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observing coronary artery disease through CT angiography

Official title: CHART Study of Coronary CT Angiography to Predict Imaging and Cardiovascular Outcomes in Patients With Coronary Artery Disease

Run by Shanghai Zhongshan Hospital · NCT05380622 · Data updated 2026-11-12

This study looks at how coronary artery disease develops in patients getting a special heart scan to see if certain plaque features can help predict heart problems in the future.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJanuary 1, 2015
Main results expectedDecember 31, 2025
Study endsDecember 31, 2030
Registry record updatedMay 25, 2022
Trial IDNCT05380622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with an indication for CCTA who can provide informed consent.

Probably not a fit

Patients with severe left ventricular dysfunction, recent myocardial infarction, or those requiring surgical intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze the development and characteristics of coronary atherosclerotic plaques in patients referred for coronary computed tomography angiography (CCTA). It will track the natural history of plaque progression or regression over time, identify precursors of plaques that may lead to acute or chronic coronary syndromes, and assess the prognostic implications of various plaque features and treatment strategies. The study will utilize advanced imaging techniques to gather detailed physiological and anatomical data on coronary lesions.

Why it matters

Potential benefit: If successful, this study could enhance understanding of coronary artery disease progression and improve treatment strategies for patients.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in understanding coronary artery disease through advanced imaging techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with an indication for CCTA.
* Qualified patients who have signed a written informed consent form.

Exclusion Criteria:

* Left ventricular ejection fraction \< 35%
* Acute ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery
* Abnormal epicardial coronary flow (TIMI flow \< 3)
* Planned coronary artery bypass graft surgery after diagnostic angiography
* Poor quality of CCTA or other reasons by core lab that are unsuitable for plaque, physiological or fat analysis
* Patients with a stent in the target vessel

Where it's running

  • Shanghai Zhongshan Hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.